Navigation Links
The Fight for His Life: Author, Family Battle Disease and Challenge Politics in the Face of Survival
Date:9/14/2007

racy Association earned him a North Carolina Volunteer Award, which was presented to McNamara days after his cancer diagnosis. McNamara is also a life member and past commander of VFW Post 6767 in Dunn, N.C. He and his wife have three children.

AuthorHouse is the premier book publisher (http://www.authorhouse.com) for emerging, self-published (http://www.authorhouse.com/GetPublished/FAQ.aspx) authors. For more information, please visit http://www.authorhouse.com.

EDITORS: For review copies or interview requests, contact:

Elizabeth Hollingsworth, Publicity Coordinator

Tel: 800-839-8640, ext. 5278

Fax: 812-961-3133

Email: ehollingsworth@authorhouse.com

(When requesting a review copy, please provide a street address.)

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE AuthorHouse
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Fight Heart disease and Pain with Meditation
2. Fight anemia by fortifying crops with iron!!!!!!!!
3. Fight arthritic pain with acupuncture
4. Special proteins to fight TB identified
5. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
6. Starch fights cancer
7. Flaxseed fights cancer risk
8. Common Cold Found to Fight Cancer Cells
9. People who fight wars may be at high risk of cardiovascular disease
10. Antibodies to fight HIV infection.
11. Gene enchances radiation therapy - A novel approach to fight cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 2Q-Med AB and Oceana Therapeutics, Inc. Take Major Step Towards SOLESTA(TM) US Regulatory Filing 3Sysmex America Receives Highest Vendor Designation from MedAssets Supply Chain Systems 51679 1Sysmex America Receives Highest Vendor Designation from MedAssets Supply Chain Systems 51679 2FRCs Tony Perkins Commends Pro life Lawmakers Who Oppose Federal Funding of Abortion 51676 1FRCs Tony Perkins Commends Pro life Lawmakers Who Oppose Federal Funding of Abortion 51676 2Sono Tek Announces First Quarter Results 51672 1Sono Tek Announces First Quarter Results 51672 2Sono Tek Announces First Quarter Results 51672 3